Benzethonium vs Idarubicin
Mechanistic comparison of Benzethonium Bactericidal cationic quaternary ammonium surfactant used as and Idarubicin based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
16
Shared Targets
21%
Jaccard Similarity
17%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Benzethonium and Idarubicin share 16 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.210 means 21% of the combined target set is bound by both compounds. The IDF-weighted score of 0.172 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.